Escherichia coli vertebral osteomyelitis and spondylodiscitis following transurethral lithotripsy: a delayed complication possibly associated with untreated asymptomatic bacteriuria – a case report Authors: Yasaman Eskandari, Saeid Amini Rarani, Mehdi Azami Published: 2026 ABSTRACT AbstractVertebral osteomyelitis and spondylodiscitis are uncommon infections, most frequently caused by Staphylococcus aureus. Gram-negative organisms such as Escherichia coli are rare etiologic agents and are usually associated with a urinary tract source. We report a case of E. coli vertebral osteomyelitis and spondylodiscitis with abscess formation in a 66-year-old man occurring 6 months after transurethral lithotripsy (TUL). The patient had evidence of preoperative pyuria suggestive of asymptomatic bacteriuria that was not definitively treated. No prophylactic or postoperative antibiotics were administered. The patient denied any intercurrent illness or alternative source of bacteremia. MRI and CT-guided biopsy were revealed vertebral osteomyelitis and spondylodiscitis at T9–T10 with a small paravertebral abscess. CT-guided biopsy of the vertebral lesion grew E. coli with the same susceptibility profile as the preoperative urine isolate: resistant to ciprofloxacin and ceftriaxone but susceptible to cefepime. The patient received intravenous cefepime for six weeks. He improved substantially within two weeks and was pain-free with normalized inflammatory markers and complete radiological resolution by the end of treatment. Follow-up at 12 months showed no recurrence. This case illustrates that untreated asymptomatic bacteriuria may rarely be associated with delayed hematogenous vertebral infection following urologic instrumentation. It underscores the importance of screening and treating bacteriuria before procedures that breach the urinary mucosa, in accordance with current guideline recommendations.Keywords: Vertebral osteomyelitis, Spondylodiscitis, Escherichia coli, Asymptomatic bacteriuria, Urologic instrumentation Background Vertebral osteomyelitis and spondylodiscitis are rare but potentially severe infections affecting the spine and intervertebral discs, with significant morbidity and sometimes mortality [1]. These infections are usually haematogenous in origin. While Staphylococcus aureus is the most common pathogen, Gram-negative bacteria such as Escherichia coli are less frequently identified but are emerging as important causative agents in certain patient populations, particularly when a genitourinary source is present [2, 3]. Asymptomatic bacteriuria (ASB) is common in elderly individuals and in patients with underlying urologic conditions. Current guidelines do not recommend routine screening and treatment of ASB in the general population, but they do recommend treatment before urologic procedures that breach the urogenital mucosa (e.g., transurethral lithotripsy (TUL), transrectal prostate biopsy) to prevent haematogenous infectious complications [4, 5]. Vertebral osteomyelitis and spondylodiscitis can present insidiously, with non-specific symptoms such as back pain and restricted spinal movement, often without fever or systemic signs [6]. Delayed recognition may lead to spinal deformity, neurological deficits, or sepsis. This case report describes a patient who developed E. coli vertebral osteomyelitis and spondylodiscitis six months after TUL, in the setting of untreated ASB. We discuss the likely but not definitively proven association, the diagnostic work-up, and the therapeutic approach while acknowledging alternative possibilities and the limitations of a single case. Case presentation A 66-year-old man with a history of hypertension, hyperlipidaemia, and hypothyroidism underwent TUL for a 12-mm left renal pelvic stone. The procedure was uneventful; no prophylactic antibiotics were administered before or after the procedure, in accordance with the urologist’s routine practice at that time. One week before TUL, routine urinalysis showed significant pyuria (25 white blood cells per high-power field). A urine culture was obtained and subsequently grew Escherichia coli at > 10⁵ colony-forming units (CFU)/mL, confirming ASB because the patient had no urinary symptoms. Despite this finding, no antimicrobial therapy was given before the procedure. The patient recovered uneventfully from TUL and remained well for approximately six months. He then developed progressive left flank pain, lower back pain, and restricted spinal movement. He denied fever, chills, weight loss, or urinary symptoms. There was no history of intercurrent urinary tract infection, dental procedures, skin infection, or other potential source of bacteremia between TUL and presentation. On physical examination, lumbar spine motion was limited by pain, but there were no focal neurological deficits. Laboratory investigations revealed a mildly elevated erythrocyte sedimentation rate (ESR) of 33 mm/h (reference range: 0–20 mm/h). C-reactive protein (CRP) was within the normal range at 2 mg/L (reference: <5 mg/L). Complete blood count, renal and liver function tests were normal. Serology for brucellosis and PCR for Mycobacterium tuberculosis were negative. Chest CT was normal. Magnetic resonance imaging (MRI) of the spine revealed vertebral osteomyelitis and spondylodiscitis at the T9–T10 levels with a small associated paravertebral abscess measuring approximately 2 × 1.5 cm (Fig. 1-A, B & C). There was no spinal cord compression or significant neurological compromise, so surgical drainage was not performed. CT-guided biopsy of the T9–T10 vertebral lesion was performed. Cultures of the biopsy specimen grew E. coli with the same antimicrobial susceptibility profile as the preoperative urine isolate: resistant to ciprofloxacin and ceftriaxone, susceptible to cefepime. Blood cultures obtained at admission were negative. Cytological examination of the biopsy showed no malignancy. MRI findings of vertebral osteomyelitis and spondylodiscitis at the T9–T10 level. (A–C) Baseline sagittal T2-weighted and contrast-enhanced T1-weighted MRI images showing vertebral osteomyelitis, spondylodiscitis, and a small paravertebral abscess. (D–F) Follow-up MRI images obtained 10 weeks after treatment completion demonstrating marked healing and complete resolution of the abscess Based on susceptibility testing, the patient received intravenous cefepime (2 g every 12 h) for six weeks. After two weeks of therapy, the patient reported substantial improvement in pain. At the end of six weeks, he was pain-free and had regained full mobility. Follow-up MRI at 10 weeks after treatment completion showed complete resolution of the abscess and marked healing of the vertebral lesions (Fig. 1-D, E & F). ESR had normalized (12 mm/h). At follow-up 12 months after treatment, there was no evidence of recurrence, and the patient had returned to all normal activities. Discussion We describe a 66-year-old man who developed E. coli vertebral osteomyelitis and spondylodiscitis six months after TUL in the setting of untreated preoperative ASB. The same E. coli strain was isolated from preoperative urine and from a CT-guided biopsy of the vertebral lesion, suggesting haematogenous seeding from the urinary tract. However, several important aspects of this case warrant careful discussion. Vertebral osteomyelitis and spondylodiscitis are uncommon but serious infections, most frequently caused by Staphylococcus aureus, while Gram-negative organisms such as E. coli are rare etiologic agents and are usually associated with a genitourinary source [1–3]. In this patient, the six-month interval between TUL and the onset of spinal symptoms is unusually long for a direct post-procedural complication. Although the identical microbiological profile supports a link between preoperative ASB and the subsequent spinal infection, we cannot entirely exclude alternative possibilities, such as an intercurrent, clinically unrecognized urinary tract infection or transient bacteremia from another occult source (e.g., gastrointestinal tract) during the months following TUL. The patient denied any such intercurrent illness, and no other source was identified. Therefore, we propose that untreated ASB likely contributed to the infection rather than stating a definitive causal relationship. The diagnosis of spondylodiscitis requires a high index of suspicion, especially in patients with a history of recent urologic instrumentation and non-specific symptoms such as back pain [4]. MRI is the imaging modality of choice because it provides detailed views of the vertebral body, intervertebral discs, and surrounding soft tissues, including abscess formation [5]. CT-guided biopsy is essential for obtaining microbiological specimens to identify the causative pathogen and determine appropriate antibiotic therapy [6]. An unusual feature of this case was the finding of a normal C-reactive protein (CRP) level (2 mg/L) with only a mildly elevated erythrocyte sedimentation rate (ESR, 33 mm/h). Active vertebral osteomyelitis typically presents with significantly elevated inflammatory markers [7]. The near-normal values in this patient may reflect a subacute or indolent presentation, a relatively small abscess burden (2 × 1.5 cm), or the absence of a robust systemic inflammatory response in an elderly patient. Clinicians should be aware that normal CRP does not exclude spondylodiscitis, and imaging should be pursued when clinical suspicion is high. The antimicrobial susceptibility pattern of the E. coli isolate showed resistance to ciprofloxacin and ceftriaxone but susceptibility to cefepime, a fourth-generation cephalosporin. Cefepime has no oral formulation; therefore, the patient received intravenous cefepime (2 g every 12 h) for a full six-week course. The excellent clinical and radiological response supports the effectiveness of this targeted regimen. Surgical drainage of the paravertebral abscess was not performed because the abscess was small (2 × 1.5 cm) and there were no neurological deficits. Antibiotic therapy alone was sufficient, and we avoided an unnecessary invasive procedure. This approach is consistent with current practice, which reserves surgical intervention for large abscesses, spinal instability, or neurological compromise [8]. Current guidelines from the Infectious Diseases Society of America (IDSA) and the European Association of Urology (EAU) recommend screening for and treating ASB only before urologic procedures that are expected to breach the urogenital mucosa, such as TUL, transurethral resection of the prostate, or transrectal prostate biopsy [9, 10]. Routine screening and treatment of ASB in the general population or before low-risk procedures are not recommended. Our case supports the rationale for following these targeted recommendations. The preoperative pyuria and positive urine culture in this patient should have prompted antimicrobial treatment before TUL, which might have prevented hematogenous seeding to the spine. We have moderated the conclusion to avoid overgeneralization, emphasizing that this single case demonstrates a possible association rather than proving causality. Conclusion This case illustrates that untreated ASB may, albeit rarely, be associated with delayed hematogenous vertebral osteomyelitis and spondylodiscitis following transurethral lithotripsy. The six-month interval suggests a protracted course, and other potential sources of bacteremia cannot be entirely excluded. Clinicians should maintain a high index of suspicion for spondylodiscitis in patients with persistent back pain after urologic instrumentation, even with normal inflammatory markers, and should follow guideline-based recommendations for screening and treating ASB before procedures that breach the urinary mucosa. Targeted antibiotic therapy guided by susceptibility testing can lead to excellent outcomes without surgery in carefully selected patients. Acknowledgements Not applicable. Abbreviations Staphylococcus aureus Escherichia coli Trans urethral lithotripsy Asymptomatic bacteriuria Magnetic resonance imaging Computed tomography scan Erythrocyte sedimentation rate C-reactive protein Author contributions Y.E. was involved in patient data collection, clinical evaluation, treatment, and medical care of the patient. M.A. performed the laboratory investigations, reviewed the relevant literature, and prepared the initial draft of the manuscript. S.A.R. contributed to the literature review, prepared the final version of the manuscript, and was responsible for nursing care of the patient. All authors read and approved the final manuscript. Funding Not applicable. Data availability The data that support the findings of this study are available from the corresponding author upon reasonable request. Declarations Ethics approval and consent to participate The research has complied with the Declaration of Helsinki and has been approved by the authors’ Research Ethics Committee of Dr. Ali Shariati Hospital in Isfahan, Iran. Informed consent was obtained from the patient. Consent for publication Written informed consent was obtained from the patient for publication of this case report. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request.